South Korea’s Medical Tourism Market: Skin Clinics Drive Record Growth

South Korea recorded more than 2 million foreign patients in 2025. Behind that national total is a business concentrated in Seoul’s clinics and heavily dependent on Chinese and Japanese demand.

South Korea’s reported foreign-patient total rose by 841,355 in 2025—more than the entire tally for 2023.

The country recorded 2,011,822 foreign patients, up 71.9% from a year earlier. Clinic-level facilities accounted for 87.7% of the total. Dermatology led the government’s breakdown by medical specialty. 1

For hospital operators, those details change the meaning of the headline. Growth in skin-treatment bookings doesn’t establish equivalent demand for cancer surgery, complex operations or long hospital stays. They are different businesses, even when national statistics group them under medical tourism.

What the patient count measures

The official foreign-patient category covers foreign nationals outside Korea’s National Health Insurance system, with specified foreign residents excluded. It measures the use of medical services, not the purpose of a traveler’s trip. The total doesn’t distinguish someone who flew to Korea for treatment from someone who booked a procedure during a holiday. 2

The ministry separately reported 2.72 million patient visits in 2025. That figure includes repeat attendance and should not be substituted for the 2.01 million patient total. Medical Korea also describes its patient-counting approach at the hospital level, so the headline should not be presented as a count of independently verified, unique medical tourists entering the country. 1 3

The 2025 patient total was roughly four times the 497,464 recorded in 2019. 3

Dermatology leads; hospital care is a separate market

Dermatology accounted for 62.9% of the ministry’s specialty-level tally in 2025, followed by plastic surgery at 11.2%. These shares use the specialty breakdown’s counting base, not the headline patient total. Adding them does not establish that three-quarters of unique visitors received cosmetic treatment. 1

The distinction also applies to the services themselves. A dermatology appointment isn’t necessarily cosmetic, and a plastic-surgery department also performs reconstructive work. Still, the ministry attributed much of the growth to demand for beauty and non-surgical treatments.

The commercial pressure is visible at individual clinics. “The competition is pushing the prices of services down,” Se-rin Lee, director of Lienjang’s aesthetic dermatology department, told Reuters in May 2026. 4

The Seoul clinic reported about 100 foreign patients a day, spending an average of 1.5 million won each—about $1,000 at the conversion used in that report. Those are the clinic’s figures, not a national spending average. 4

Internal medicine represented 9.2% of the specialty tally and health-screening centers 3.1%. These services sit alongside beauty care, but account for a much smaller share of recorded activity. 1

Four markets account for 78% of the total

China and Japan together supplied 60.6% of Korea’s reported foreign patients in 2025. Adding Taiwan and the United States brings the share to 78.4%.

Source: Ministry of Health and Welfare and KHIDI figures published by the Korea Tourism Organization. Shares are rounded.

Chinese patient numbers rose 137.5% from 2024, Taiwanese numbers 122.5%, and US numbers 70.4%. The ministry linked the expansion to beauty demand, Korean cultural exports, flight connections and visa-free access for some Chinese group travelers. It did not assign a separate growth contribution to each factor. 1

Patients were recorded from 201 countries, but the two largest markets supplied more than half the total. A clinic dependent on Japanese bookings is exposed to the yen-won exchange rate. One reliant on Chinese visitors is exposed to Chinese travel rules. The number of countries on a clinic’s client list says little about how badly a fall in its largest market would hurt.

Seoul takes most of the business

Seoul accounted for 87.2% of reported foreign patients in 2025. It also held 62.5% of the medical institutions registered to attract them. 1

That concentration gives patients a choice of clinics without changing cities. It also puts providers into direct competition for the same visitors. A clinic in Gangnam is competing with nearby clinics as well as providers abroad.

Busan’s foreign-patient count grew 151.5% in 2025 and Jeju’s rose 114.7%. Both started from much smaller bases than Seoul. Fast percentage growth outside the capital has not yet changed its dominance. 1

Regional providers must give patients a reason to choose them over the larger concentration of clinics in Seoul. For specialist hospitals, that means explaining which clinicians and treatments justify the journey, alongside the transport and language support needed to make it practical.

The spending estimate is not clinic revenue

The Korea Institute for Industrial Economics and Trade estimated that foreign patients and their companions spent 12.5 trillion won on medical tourism in 2025. Medical services represented 3.3 trillion won of that amount. The government release expressed those figures as approximately $8.4 billion and $2.2 billion, respectively. 1

The larger number includes the wider trip, not just treatment. Neither should be described as an audited total of clinic receipts. They are estimates from an economic analysis.

The same analysis estimated 22.8 trillion won in domestic production effects. That is another measure again: it attempts to capture spending through the economy, not an additional pot of medical-tourism revenue. Adding it to patient spending would misrepresent the size of the market.

A clinic’s profitability depends on revenue per treatment, the cost of attracting a patient, staff costs, repeat bookings and the expense of handling complications. None of those appears in the national patient count.

Registration is not accreditation

Medical institutions that attract foreign patients must register with the relevant local government. Registration requirements include professional staffing standards and medical-malpractice insurance or indemnity coverage that includes foreign patients. Medical Korea provides tools for checking registered institutions. 6

That registration confirms a regulatory status. It does not certify every doctor’s expertise or guarantee the outcome of a procedure.

Korea’s separate, voluntary KAHF accreditation assesses services for foreign patients and patient-safety systems. Its published framework covers 44 foreign-patient service criteria and 92 safety criteria, including interpretation, medication management and infection control. 7

A provider can therefore be registered without holding KAHF accreditation. Patients and referral agencies should check which status a clinic actually holds, rather than treating “government registered” and “accredited” as interchangeable.

Neither status answers every question about the proposed treatment. Who will perform it? What are that clinician’s qualifications? Where will a patient be transferred if the clinic cannot manage a complication? Those details belong in the decision before a deposit is paid.

Records and responsibility after the flight home

An itemized quote should set out the procedure, medication, follow-up appointments and any costs excluded from the price. Patients also need written recovery instructions and a named clinical contact. A booking agent’s messaging account is not a substitute for a documented medical follow-up plan.

Language support must cover consent and discharge as well as sales. Patients need to understand the risks, alternatives and instructions, and have copies of their records to share with a doctor at home.

There is a formal route for disputes. The Korea Medical Dispute Mediation and Arbitration Agency accepts applications from overseas by email or fax. Its instructions require Korean translations when applications are prepared in English. That is a concrete cost and administrative burden for someone pursuing a case after leaving Korea. 8

Referral agreements should specify who supplies the records, who arranges translation, and who remains responsible for communicating with the patient after treatment.

Two dates that belong in providers’ plans

December 31, 2025, was the statutory cutoff for eligible cosmetic medical services under Korea’s foreign-tourist VAT-refund provision. An old webpage promising that refund is not a sound basis for a 2026 price quotation. Providers should state the tax-inclusive price and explain any claimed refund eligibility in writing. 9

May 27, 2027, is the effective date of new foreign-patient telemedicine provisions enacted in May 2026. They allow eligible clinicians at registered institutions to provide pre- and post-treatment remote care, subject to implementation rules and the law in the patient’s country of residence. The provisions are not yet in force as of this article’s publication. 10

Hospitals and clinics preparing for the change need to assign clinicians to remote follow-up, establish when to refer patients for an examination, and check where they can lawfully provide those services.

Before a patient leaves Korea, the discharge plan should answer three questions: who will review a problem after the flight home, where the patient should seek in-person care, and what the agreement says about who pays for it.